Global Fund taps pharmaceutical expertise in China

The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical companies to develop and market drugs that will help defeat AIDS, tuberculosis and malaria all over the world.

To advance a new framework for planning, purchasing and delivering drugs that can prevent and treat these three infectious diseases, the Global Fund and the China Chamber of Commerce for Import and Export of Medicines and Health Products convened a conference of Chinese drug suppliers in Shanghai last week.

“China is the world’s leader in making active ingredients for drugs, and we need to work together,” Christopher Game, chief procurement officer at the Global Fund, told the conference, adding: “Our goal is to be able to offer long-term contracts and fair return on investment. We know we can do it.”